Abstract
African trypanosomes produce some prostanoids, especially PGD2, PGE2 and PGF2α (Kubata et al. 2000, J. Exp. Med. 192: 1327–1338), probably to interfere with the host's physiological response. However, addition of prostaglandin D2 (but not PGE2 or PGF2α) to cultured bloodstream form trypanosomes led also to a significant inhibition of cell growth. Based on morphological alterations and specific staining methods using vital dyes, necrosis and autophagy were excluded. Here, we report that in bloodstream form trypanosomes PGD2 induces an apoptosis-like programmed cell death, which includes maintenance of plasma membrane integrity, phosphatidylserine exposure, loss of mitochondrial membrane potential, nuclear chromatin condensation and DNA degradation. The use of caspase inhibitors cannot prevent the cell death, indicating that the process is caspase-independent. Based on these results, we suggest that PGD2-induced programmed cell death is part of the population density regulation as observed in infected animals.
Similar content being viewed by others
Introduction
African trypanosomes cause sleeping sickness in humans and severe epidemics in livestock. Owing to antigenic variation, the course of infection is characterized by parasitic waves, which peak every 8 to 10 days; untreated, the infection is lethal. Although the decline of parasite density is attributed to the appearance of specific antibodies,1, 2 immunosuppressed animals also show a regular increase and decrease in parasite numbers,3, 4, 5 and this behavior is even observed in vitro, if culture media are replaced at regular intervals.6 Thus, beside the control of parasitemia by the immune system of the host, cell density is also regulated by the parasite itself.7, 8, 9
Following up reports about an increase of prostaglandin (PG) levels in the serum and cerebrospinal fluid of sleeping sickness patients,10 we have shown that trypanosomes produce PGD2, PGE2 and PGF2α from arachidonic acid.11, 12 These PGs led to a broad variety of different physiological effects in higher eukaryotes13 and their accumulation in serum coincides remarkably with symptoms observed during trypanosomiasis, such as fever, pain, immunosuppression, dysregulation of sleep/wake cycles and others. So far, it is not clear why protozoa produce PGs, but it is tempting to speculate that these parasites may have adopted the formation of PGs to modify host reactions for their own benefit. In addition, we also found that PGF2α was mainly produced in fast dividing forms of the parasite such as the slender bloodstream form and the procyclic insect form and was scarcely secreted into the media, while PGD2 was mainly produced by the nondividing stumpy bloodstream form and was primarily secreted.11
Here we report the effect of PGD2 on cellular growth of Trypanosoma brucei bloodstream form under in vitro culture conditions. As judged from our results, PGD2 (but not PGE2 and PGF2α) induces a programmed cell death (PCD) with characteristic features of apoptosis. Interestingly, apoptosis was also induced by PGs in higher eukaryotes.14, 15, 16, 17
Since protozoa do not contain caspases,18 the classical apoptosis mechanism cannot work in single-cell organisms. However, published data indicate that apoptosis can occur in the complete absence of caspases.19, 20, 21, 22 Additionally, a considerable number of investigations have been reported, showing that at least some of the typical PCD features like DNA fragmentation, autophagy, phosphatidylserine exposure, decrease of mitochondrial membrane potential, etc can be observed in protozoa like Leishmania,23, 24 T. cruzi,25 T. brucei,26, 27 Tetrahymena,28, 29 Blastocystis,30 Dictyostelium,19, 31, 32 yeast33 and even in bacteria.34 We propose that the induction of cell death by PGD2 in bloodstream form trypanosomes could be involved in cell density regulation.
Results
Growth inhibition induced by PGD2
Trypanosomes produce PGs from arachidonic acid, which are released into the culture media.11 In addition to effects on the host, like immune suppression or sleep induction, we questioned if PGs may also have an influence on the growth characteristics of trypanosomes. Indeed, addition of PGD2 to trypanosomes in culture led to a dose-dependent decrease of cell growth (Figure 1a). The IC50, that is, the concentration necessary to inhibit cell growth by 50% was 3.7 μM for PGD2. Interestingly, the IC50 for PGE2 was 159 μM and for PGF2α 199 μM. The PGD2 inhibition was confirmed by a proliferation assay measuring the incorporation of [3H]-thymidine into newly formed DNA (Figure 1b). PGD2 and PGE2 are very closely related isomers, which differ only by the inverse position of the keto- and the hydroxyl-group on carbon atoms 9 and 11, respectively (Figure 1c). Since the IC50 of PGE2 was 43-fold higher as compared with PGD2, our results clearly indicate that the inhibitory effect of PGD2 on cell growth of T. brucei bloodstream forms is specific and not due to the mere hydrophobic structure of the compound.
Morphological changes of trypanosomes induced by PGD2
In order to detect morphological changes due to PGD2 treatment, trypanosomes were grown for 24 h in the presence or absence of 5 μM PGD2, monitored by light microscopy and prepared for scanning (SEM) and transmission (TEM) electron microscopy. Using light microscopy, we detected that the amount of cells containing only one nucleus and expressing more than one flagellum was drastically elevated (Figure 2a and b). This observation of unusual dividing forms was clearly confirmed by SEM images, which also revealed a high number (up to 80%) of trypanosomes with at least two flagella (Figure 2d–f), and by TEM images (Figure 3h). Interestingly, here we also observed the appearance of two flagella emerging from the same flagella pocket, indicating an abnormal cell division (Figure 3f and g). In addition to these observations, condensation of chromatin in distinct areas of the nucleus, a characteristic feature of apoptosis in higher eukaryotes, was often detected (Figure 3b–d). Finally, we observed dilated mitochondria (readily recognized by their two membranes; Figure 3k, m and n) and an increase of vacuole-like structures (Figure 3b, d, f and k).
Search for necrosis
Necrosis was excluded using propidium iodide, which stains only necrotic cells due to distortion of the plasma membrane integrity. Accordingly, 95% of digitonin-treated cells showed a clear staining after an incubation time of 5 min as judged by flow cytometric analysis. In contrast, only 2.7% of trypanosomes treated for 24 h with PGD2 and 2.4% of control cells were stained. Even after an incubation time of 32 h, staining of treated cells remained below 5% (see Figure 6a and b, necrosis).
Search for autophagy
Morphological alterations following PGD2 treatment of trypanosomes, especially the increase of vacuole-like structures, prompted us to consider autophagic mechanisms for the observed cell death. Monodansylcadaverine is especially taken up by autophagic cells and stains autophagosome structures.35 However, a staining difference between control cells and PGD2-treated cells could not be observed within 36 h. Adenosine, 3-methyladenine and wortmannin have been described as autophagy inhibitors.36, 37, 38, 39 However, as shown in Figure 4a, 3-methyladenine and wortmannin were not able to revert the PGD2 effects at concentrations up to 100 μM or 50 nM, respectively. Adenosine (50 μM) had a minor effect on PGD2-treated trypanosomes, as it prolonged the survival time for about 6 h (Figure 4b). Higher adenosine concentrations had themselves an inhibitory effect on cell growth per se, while lower concentrations did not change the growth characteristics of PGD2-treated or nontreated parasites. To further check the observed effects of adenosine, deoxycoformycin (Nipent), a drug well known to enhance the adenosine effect on autophagic cells,38 was administered together with adenosine, but did not revert the observed cell death (Figure 4b).
Search for apoptosis
In order to analyze PGD2-induced cell death in T. brucei, we used terminal deoxynucleotidyl transferase-mediated desoxyuridine triphosphate (dUTP) nick-end labeling (TUNEL) test and fluorescence-activated cell sorter (FACS) analysis, which are well-established methods to investigate apoptosis in higher eukaryotes.
TUNEL staining
This method is applied to detect DNA double-strand ruptures. Cells taken from different growth phases were fixed with formaldehyde and placed on immunoslides (Biomerieux, Nürtingen). Free DNA ends were labeled using modified dUTP, and the ratio of labeled and unlabeled nuclei was visually monitored. No staining differences were observed between treated (5 μM PGD2) and control cells after an incubation time of up to 12 h; only a background staining of about 1% was detected. In contrast, after an incubation time of 24 h in culture about 50% of treated cells showed positive nuclear staining, while only 3% of control cells were labeled (Figure 5a and b). The addition of PGF2α or PGE2 (10 μM each) gave no positive staining if compared with control cells (data not shown).
FACS analysis
In order to determine the DNA content, treated (5 μM PGD2) and control cells were lysed hypotonically in 10 mM phosphate buffer containing 6 μM digitonin. DNA within the nuclei was stained using propidium iodide, before the nuclei were sorted according to size and fluorescence labeling using a FACScalibur® cell sorter (BD Biosciences). The respective distribution chart clearly discriminated between nuclei of the G1, S or G2 cell cycle stage and nuclei with a reduced DNA content due to DNA degradation processes. The latter fraction represents an established apoptosis marker in higher eukaryotic cells.40, 41, 42 As shown in Figure 6a, there was virtually no difference between control and treated cells for up to 20 h, while after 24 h most of the nuclei of treated cells showed a shift towards the area of degraded DNA. Quantification of nuclei in the area of DNA degradation, as compared with the number of total nuclei, revealed that the background of cells with a low DNA content was 4.6±0.9%, while in PGD2-treated cells, the ratio increased to 13.4±2.0 and 57.6±1.5% after 24 and 32 h of cell growth, respectively (Figure 6b, DNA degradation). Nuclei of cells grown in the presence of 10 μM PGF2α or PGE2 showed the same behavior as control cells with a regular distribution between G1, S and G2 phase. Interestingly, quantification of nuclei in the areas of the different cell cycle stages indicated an increase of about 15% of cells in the G1 phase, which was paralleled by a 10% decrease from the G2 and a 5% decrease from the S phase in PGD2-treated cells after 24 h (Figure 6c). These differences increased further with time, leading to an increase of about 30% of cells in the G1 phase and a corresponding decrease by 20% from the G2 and by 10% from the S phase after 32 h (Figure 6c). In addition, cell death induced by PGD2 was associated with a loss of mitochondrial membrane potential (Ψm) as monitored by tetramethylrhodamine uptake (Figure 6a, Ψm). After 32 h, 41.8±3.4% of PGD2-treated cells showed a low Ψm compared with only 8.1±2.6% of control cells (Figure 6b, Ψm). Control experiments using valinomycin (100 nM) abolished tetramethylrhodamine uptake completely, demonstrating that uptake of this dye is strictly driven by Ψm.
Use of caspase inhibitors
In addition to the above-mentioned experiments, we have used the apoptosis inhibitors zVAD and DEVD-CHO each one alone and together with PGD2, to see if they can stop PCD induction. As shown in Figure 7, both drugs led to a strong growth inhibition of trypanosomes at the maximum concentrations used, but had no visible effects on growth inhibition induced by PGD2 if administered in sublethal doses. These data suggest that the PCD process induced by PGD2 treatment is caspase independent.
Inhibition of PGD2 effect by cycloheximide
To further explore the mechanism of PGD2-induced cell death, the translation inhibitor cycloheximide was used. Thus, cells from stationary phase were preincubated for 1 h at 37°C with 10 μg/ml cycloheximide. Thereafter, prostaglandin D2 was added and cell density was monitored during the next 6 h. As shown in Figure 8a, PGD2 alone induced cell death, which was interestingly abolished by cycloheximide. Additionally, phosphatidyl serine exposure was assayed. A significant difference (P<0.05) was obtained between control cells and PGD2-treated cells after a 6 h incubation, which was clearly blocked by cycloheximide (Figure 8b). These results suggest that the mode of action of PGD2 requires de novo protein synthesis.
Discussion
Trypanosomes produce and release a set of PGs,11 which certainly influences the host–parasite relationship. Here, we questioned if these cytokines by means of an autocrine or a paracrine regulation have an influence on the parasite's growth. Addition of PGE2 or PGF2α had no visible effects on trypanosomes, that is, cells grew normally and showed no differences in their growth characteristics or morphology as compared with control cells. In contrast, addition of PGD2 showed clear inhibitory effects on growing trypanosomes. The IC50 values revealed that PGD2 is about 50-fold more potent than PGE2 or PGF2α. These results clearly confirm that cell growth inhibition induced by PGD2 is specific.
Growth inhibition occurred within 8 to 12 h in logarithmically growing cells and within 2 h in stationary phase cells following PGD2 treatment. In addition, cells pretreated with 8-(4-chlorophenylthio)-cAMP, a membrane-permeable cAMP analog described to induce differentiation from slender to stumpy form,43 were more sensitive to PGD2 than non-pretreated cells (data not shown). These results suggest that PGD2 works primarily on stumpy forms.
The PGD2 concentration required to inhibit cell growth of T. brucei in vitro was in the micromolar range (IC50=3.7 μM), and thus similar to or lower than concentrations needed in comparable studies using different eukaryotic cells.15, 17, 44, 45, 46 However, the active concentration of free PGs will be considerably lower, since PGs readily bind to serum albumin.47, 48, 49, 50 Using our conditions, 80% of PGD2 added to the culture media was bound to serum albumin within 1 h after drug addition. Furthermore, due to the presence of albumin, PGD2 is readily metabolized to different PGD2 derivatives.51 Thus, the effective PGD2 concentration is in the nanomolar range, which is comparable to physiologically relevant concentrations. We are currently investigating the metabolite production from PGD2 under our experimental conditions and their possible effects on T. brucei.
As judged by FACS analysis, PGD2 treatment led to a cell cycle arrest in the G1 phase. In addition, observation of cells by light microscopy, SEM and TEM indicated an increased number of cells in a dividing state after 24 h treatment with PGD2. In this case, most cells contained more than one flagellum but usually only one nucleus, as confirmed by 4,6-diamidino-2-phenylindole (DAPI) staining. Thus, PGD2 treatment led to an arrest during cell division because formation of new flagella occurred but division of the nucleus could not proceed. These results suggest that PGD2 is involved in cell cycle regulation of T. brucei, as it was also reported for several cell types from other organisms.52, 53, 54
Since we found no indication for necrosis, we assumed a PCD due to PGD2 treatment. PCD is accurately defined as an active process that is dependent on signaling events in the dying cell and requires gene expression.20, 55 Treatment with cycloheximide blocked the PGD2 effect, indicating that cell death induced by PGD2 is a result of an active cellular process, which can be stopped by protein synthesis inhibition. PCD may appear as caspase-dependent or -independent apoptosis, as autophagy, as PCD type III56 or as paraptosis.55 To discriminate between these types, we applied a set of well-known criteria. Although autophagy was suggested by the observation of clearly increased lysosomal structures, we did not observe autophagosomes using monodansylcadaverine and no reversion of autophagy by 3-methyladenine, wortmannin, adenosine or adenosine plus nipent, respectively. Based on these results, there is no evidence for induction of autophagy by PGD2 treatment. PCD type III is characterized by disintegration of cells into fragments without involvement of lysosomes, which was not observed in our case either. Owing to the lack of caspases in T. brucei, a caspase-dependent apoptosis or paraptosis were excluded. Interestingly, we discovered five metacaspase genes in trypanosomes, which have all been cloned and heterologously expressed in yeast. One of the gene products led to a petite phenotype and induced clonal cell death in Saccharomyces cerevisiae.57 However, as judged from our recent results, metacaspases in trypanosomes may be involved in modulation of the dynamics of membrane-associated proteins, but obviously do not participate in PCD.58
Our findings indicate that PGD2-treated cells can undergo cell death that shares essential characteristics with apoptosis in higher eukaryotes and other protozoa.23, 28, 30, 59 PGD2 treatment induced nuclear segmentation, chromatin condensation and DNA degradation, as observed by TEM, FACS and TUNEL test. In addition, we observed a dilation of the mitochondrion in TEM, and a decrease of the mitochondrial membrane potential using FACS analysis as well as phosphatidylserine exposure. However, due to the lack of caspases and the failure of the cysteine protease inhibitors DEVD-CHO and zVAD to inhibit PCD, we consider the PCD induced by PGD2 in T. brucei to be caspase independent. This cell death type has also been reported in Dictyostelium19 T-lymphocytes20 and others (as reviewed in Lorenzo and Susin21). It is interesting to note that caspase inhibitors do not prevent apoptosis in most mammalian models either, and that the morphology of dying cells in these cases resembled that of unicellular eukaryotes, which lack caspases.60
Our findings suggest that PGD2 secretion by trypanosomes is involved in cell cycle regulation and provide evidence for the existence of a caspase-independent PCD.
Bloodstream forms of African trypanosomes differentiate from dividing slender to nondividing stumpy forms, with the latter preadapted for fly transfection. If stumpy forms are not taken up by a tsetse fly during a blood meal, these cells survive for only 2 to 3 days,61 especially the stumpy forms produce PGD2,11 which – as we describe here – will lead to PCD. Taken these data together, we propose a two-step mechanism to control cell density in infected animals: (1) slender forms produce a so far unknown differentiation factor,6, 62 which, depending on cell density, induces differentiation to stumpy forms.9, 63 (2) Stumpy forms produce PGD2, which induces cell death primarily of stumpy form cells. Since PGs have a short half-life and thus work as local mediators only, this model provides a mechanism for a sustained infection, because it would certify that cell density is locally regulated, leading to a controlled parasite density throughout the host. On the other hand, a sustained infection would never be in question, because dividing slender forms would not be affected by PCD. The appearance of specific antibodies would thus provide an additional mechanism to keep the parasitemia low. It should be kept in mind, however, that cell density regulation also occurs in cell culture in the absence of antibodies.6
Materials and Methods
Chemicals
PGs of the highest analytical grade were obtained either from Sigma Chemicals (Deisenhofen, Germany) or from Cayman Chemicals (Ann Arbor, MI, USA). Methyl-[3H]-thymidine was purchased from Hartmann Analytic (Braunschweig, Germany). All other chemicals used were of the highest analytical reagent grade and obtained from Sigma Chemicals (Deisenhofen, Germany). PGs have been used as a 4 mM stock solution in ethanol and diluted to the respective concentration using media.
Parasites
T. brucei MITat 1.2 (VSG-variant 221) of the monomorphic strain EATRO 427 were used throughout the experiments. Bloodstream forms were grown in axenic culture at 37°C and 5% CO2 as described earlier.6, 62 For the experiments described here, parasites were taken from frozen stabilates, seeded at a cell density of 2 × 105 cells/ml and grown for about 18 h until a cell density of 8 × 105 cell/ml was reached. By adding fresh media, cells were adjusted to 2 × 105 trypanosomes/ml and split into the desired number of individual culture flasks. At the same time, PGs or ethanol were added at the denoted concentrations and cells were grown at 37°C in a CO2 incubator. All experiments were performed at least in triplicate.
Proliferation assay
The cellular proliferation was determined by measuring thymidine incorporation. Cells were adjusted to 2 × 105 trypanosomes/ml and seeded in 200 μl aliquots into 96-well microtiter plates. After an 24 h incubation at 37°C and 5% CO2, cells were pulsed for 4 h with 1 μCi/well of methyl-[3H]-thymidine before they were harvested and counted in a liquid scintillation counter. Incubation of media alone was used to estimate the radioactivity background. Results are represented as counts per minute (c.p.m.).
Cytotoxicity assay
The IC50 values were determined according to Bodley et al.64 Exponentially growing parasites were diluted to 2 × 105 cells/ml, placed in a 96-well microtiter plate (199 μl) and grown with or without PGs (1 μl/well) at different concentrations. Plates were incubated for 24 h at 37°C and 5% CO2. Cell growth was stopped by the addition of 20 μl lysis buffer containing p-nitrophenyl phosphate (20 mg/ml in 1 M sodium acetate, pH 5.5 with, 1% Triton X-100). Finally, following a 6 h incubation at 37°C, the phosphatase activity was measured at 405 nm using an ELISA reader (MRX II, Dynex Technologies, Middlesex, England).
Morphological analysis
Light and fluorescence microscopy
PGD2-treated or nontreated cells were stained with a fluorescent dye (DAPI; purchased from Sigma). After 24 h, aliquots from each culture were withdrawn and washed twice with phosphate-buffered saline (PBS). Cells were resuspended in 200 μl PBS, placed on a slide and fixed with methanol. DAPI staining was performed for 5 min (0.1 μg/ml final concentration)., Slides were washed three times thereafter and examined using an Olympus BH2 fluorescence microscope.
Transmission electron microscopy
For TEM, at least 108 trypanosomes were taken at intervals during in vitro cultivation. Fixation was performed in 2% (vol/vol) glutaraldehyde in 0.2 M sodium cacodylate buffer containing 0.12 M sucrose for 1 h at 4°C. After washing four times (10 min each) and storage over night in sodium cacodylate buffer, cells were postfixed in osmium tetroxide (1.5%, wt/vol) and stained in 0.5% uranyl acetate.65 Dehydration in ethanol, clearing in propylene oxide and embedding in Agar 100 (equivalent to Epon 812) was performed according to standard procedures.66 Sections were stained in 5% (wt/vol) uranyl acetate and 0.4% (wt/vol) lead citrate.
Scanning electron microscopy
For SEM, the same fixation and in block staining protocol as described above was applied. Cells were sequentially dehydrated in 50, 75, 95 and 100% ethanol. Critical point drying and gold-palladium sputter staining was performed using standard protocols.
TUNEL test
To detect DNA double-strand ruptures, we applied the TUNEL test, using the in situ cell death detection kit obtained from Roche, Mannheim. The assay procedure was performed as described previously.67 The ratio of cell death was determined by counting three times about 100 cells each and dividing the number of cells showing a clearly stained nucleus by the total number of trypanosomes counted, to yield the percentage of stained cells.
FACS analysis
DNA content
In order to determinate the content of DNA within the nucleus, a propidium iodide staining method was used.40 For this purpose, at least 5 × 105 cells were spun down, washed once with PBS (pH 7.4) and lysed in 100 μl phosphate buffer (10 mM, pH 7.4; containing 6 μM digitonin). Samples were vortexed and incubated for 30 min at room temperature. Nuclei were stained with a propidium iodide solution (10 μg/ml final concentration in 10 mM phosphate buffer) 1 h before measurement of the nuclei in a FACSCalibur® apparatus (Becton Dickinson & Co., NJ, USA) using FACSflow®.
Mitochondrial membrane potential
To determine the mitochondrial membrane potential, 106 cells/ml were incubated in MEM containing 25 nM of tetramethylrhodamine (TMRE) for 30 min at 37°C and immediately loaded into the cell sorter for further analysis. The ionophore valinomycin (100 nM) was used as control for a complete depolarization of the inner mitochondrial membrane.
Phosphatidylserine exposure
Exposed phosphatidylserine was detected on the outer membrane of cells using annexin-V-fluos® (Roche, Mannheim). Cells were washed in HEPES buffer (10 mM, pH 7.4; containing 140 mM NaCl and 5 mM CaCl2) and incubated for 15 min with annexin V at 4°C. Fluorescence was measured using FACS analysis as described before.
Cellular permeability
Plasma membrane integrity of PGD2-treated or nontreated trypanosomes (2 × 106 cells/ml) was assessed using propidium iodide (5 μg/ml) staining. Cells were analyzed by flow cytometry, using digitonin (6 μM) as a positive control to induce necrosis.
Abbreviations
- dUTP:
-
desoxyuridinetriphosphate
- ΔΨm:
-
mitochondrial membrane potential
- FACS:
-
fluorescence-activated cell sorter
- PCD:
-
programmed cell death
- PG:
-
prostaglandin
- SEM:
-
scanning electron microscopy
- TEM:
-
transmission electron microscopy
- TUNEL:
-
terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling
References
Webster P, Russo DC and Black SJ (1990) The interaction of Trypanosoma brucei with antibodies to variant surface glycoproteins. J. Cell Sci. 96: 249–255
Cross GA (1996) Antigenic variation in trypanosomes: secrets surface slowly. Bioessays 18: 283–291
Black SJ, Sendashonga CN, O'Brien C, Borowy NK, Naessens M, Webster P and Murray M (1985) Regulation of parasitaemia in mice infected with Trypanosoma brucei. Curr. Top. Microbiol. Immunol. 117: 93–118
Black SJ, Sendashonga CN, Webster P, Koch GL and Shapiro SZ (1986) Regulation of parasite-specific antibody responses in resistant (C57BL/6) and susceptible (C3H/HE) mice infected with Trypanosoma (trypanozoon) brucei brucei. Parasite Immunol. 8: 425–442
Mahan SM and Black SJ (1989) Differentiation, multiplication and control of bloodstream form Trypanosoma (Duttonella) vivax in mice. J. Protozool. 36: 424–428
Hesse F, Selzer PM, Muhlstadt K and Duszenko M (1995) A novel cultivation technique for long-term maintenance of bloodstream form trypanosomes in vitro. Mol. Biochem. Parasitol. 70: 157–166
Reuner B, Vassella E, Yutzy B and Boshart M (1997) Cell density triggers slender to stumpy differentiation of Trypanosoma brucei bloodstream forms in culture. Mol. Biochem. Parasitol. 90: 269–280
Seed JR and Black SJ (1997) A proposed density-dependent model of long slender to short stumpy transformation in the African trypanosomes. J. Parasitol. 83: 656–662
Tyler KM, Higgs PG, Matthews KR and Gull K (2001) Limitation of Trypanosoma brucei parasitaemia results from density-dependent parasite differentiation and parasite killing by the host immune response. Proc. R. Soc. Lond. Scr. B. 268: 2235–2243
Pentreath VW, Rees K, Owolabi OA, Philip KA and Doua F (1990) The somnogenic T lymphocyte suppressor prostaglandin D2 is selectively elevated in cerebrospinal fluid of advanced sleeping sickness patients. Trans. R. Soc. Trop. Med. Hyg. 84: 795–799
Kubata BK, Duszenko M, Kabututu Z, Rawer M, Szallies A, Fujimori K, Inui T, Nozaki T, Yamashita K, Horii T, Urade Y and Hayaishi O (2000) Identification of a novel prostaglandin f(2alpha) synthase in Trypanosoma brucei. J. Exp. Med. 192: 1327–1338
Kubata BK, Duszenko M, Kabututu Z, Rawer M, Szallies A, Inui T, Urade Y and Hayaishi O (2002) Enzymatic formation of prostaglandin D2, E2, and F2 α in the parasitic protozoan Trypanosoma brucei. International Congress Series 1233: 461–466
Marks F and Furstenberger G (1999) Prostaglandins, Leukotrienes and Other Eicosanoids: From Biogenesis to Clinical Application. Weinheim, New York, Chichester, Brisbane, Singapore, Toronto: Wiley-VCH
Gilmour RS and Mitchell MD (2001) Nuclear lipid signaling: novel role of eicosanoids. Exp. Biol. Med. (Maywood) 226: 1–4
Li L, Tao J, Davaille J, Feral C, Mallat A, Rieusset J, Vidal H and Lotersztajn S (2001) 15-Deoxy-delta 12,14-prostaglandin j2 induces apoptosis of human hepatic myofibroblasts. a pathway involving oxidative stress independently of peroxisome-proliferator-activated receptors. J. Biol. Chem. 276: 38152–38158
Straus DS and Glass CK (2001) Cyclopentenone prostaglandins: new insights on biological activities and cellular targets. Med. Res. Rev. 21: 185–210
Ward C, Dransfield I, Murray J, Farrow SN, Haslett C and Rossi AG (2002) Prostaglandin D2 and its metabolites induce caspase-dependent granulocyte apoptosis that is mediated via inhibition of I kappa B alpha degradation using a peroxisome proliferator-activated receptor-gamma-independent mechanism. J. Immunol. 168: 6232–6243
Koonin EV and Aravind L (2002) Origin and evolution of eukaryotic apoptosis: the bacterial connection. Cell Death Differ. 9: 394–404
Olie RA, Durrieu F, Cornillon S, Loughran G, Gross J, Earnshaw WC and Golstein P (1998) Apparent caspase independence of programmed cell death in Dictyostelium. Curr. Biol. 8: 955–958
Jaattela M and Tschopp J (2003) Caspase-independent cell death in T lymphocytes. Nat. Immunol. 5: 416–423
Lorenzo HK and Susin SA (2004) Mitochondrial effectors in caspase-independent cell death. FEBS Lett. 557: 14–20
Lockshin RA and Zakeri Z (2004) Caspase-independent cell death? Oncogene 23: 2766–2773
Arnoult D, Tatischeff I, Estaquier J, Girard M, Sureau F, Tissier JP, Grodet A, Dellinger M, Traincard F, Kahn A, Ameisen JC and Petit PX (2001) On the evolutionary conservation of the cell death pathway: mitochondrial release of an apoptosis-inducing factor during Dictyostelium discoideum cell death. Mol. Cell. Biol. 12: 3016–3030
Lee N, Bertholet S, Debrabant A, Muller J, Duncan R and Nakhasi HL (2002) Programmed cell death in the unicellular protozoan parasite Leishmania. Cell Death Differ. 9: 53–64
Piacenza L, Peluffo G and Radi R (2001) L-arginine-dependent suppression of apoptosis in Trypanosoma cruzi: contribution of the nitric oxide and polyamine pathways. Proc. Natl. Acad. Sci. USA 98: 7301–7306
Welburn SC and Murphy NB (1998) Prohibitin and RACK homologues are up-regulated in trypanosomes induced to undergo apoptosis and in naturally occurring terminally differentiated forms. Cell Death Differ. 5: 615–622
Welburn SC, Lilico S and Murphy NB (1999) Programmed cell death in procyclic form Trypanosoma brucei rhodesiense – identification of differentially expressed genes during Con A induced death. Mem. Inst. Oswaldo Cruz 94: 229–234
Mpoke S and Wolfe J (1996) DNA digestion and chromatin condensation during nuclear death in Tetrahymena. Exp. Cell Res. 225: 357–365
Jaso-Friedmann L, Leary JH and Evans DL (2000) Role of nonspecific cytotoxic cells in the induction of programmed cell death of pathogenic protozoans: participation of the Fas ligand–Fas receptor system. Exp. Parasitol. 96: 75–88
Nasirudeen AM, Tan KS, Singh M and Yap EH (2001) Programmed cell death in a human intestinal parasite, Blastocystis hominis. Parasitology 123: 235–246
Arnoult D, Akarid K, Grodet A, Petit PX, Estaquier J and Ameisen JC (2002) On the evolution of programmed cell death: apoptosis of the unicellular eukaryote Leishmania major involves cysteine proteinase activation and mitochondrion permeabilization. Cell Death Differ. 9: 65–81
Tatischeff I, Petit PX, Grodet A, Tissier JP, Duband-Goulet I and Ameisen JC (2001) Inhibition of multicellular development switches cell death of Dictyostelium discoideum towards mammalian-like unicellular apoptosis. Eur. J. Cell Biol. 80: 428–441
Frohlich KU and Madeo F (2000) Apoptosis in yeast – a monocellular organism exhibits altruistic behaviour. FEBS Lett. 473: 6–9
Lewis K (2000) Programmed death in bacteria. Microbiol. Mol. Biol. Rev. 64: 503–514
Biederbick A, Kern HF and Elsasser HP (1995) Monodansylcadaverine (MDC) is a specific in vivo marker for autophagic vacuoles. Eur. J. Cell Biol. 66: 3–14
Seglen PO and Gordon PB (1982) 3-Methyladenine: specific inhibitor of autophagic/lysosomal protein degradation in isolated rat hepatocytes. Proc. Natl Acad. Sci. USA 79: 1889–1892
Caro LH, Plomp PJ, Wolvetang EJ, Kerkhof C and Meijer AJ (1988) 3-Methyladenine, an inhibitor of autophagy, has multiple effects on metabolism. Eur. J. Biochem. 175: 325–329
Samari HR and Seglen PO (1998) Inhibition of hepatocytic autophagy by adenosine, aminoimidazole-4-carboxamide riboside, and N6-mercaptopurine riboside. Evidence for involvement of amp-activated protein kinase. J. Biol. Chem. 273: 23758–23763
Munafo DB and Colombo MI (2001) A novel assay to study autophagy: regulation of autophagosome vacuole size by amino acid deprivation. J. Cell Sci. 114: 3619–3629
Nicoletti I, Migliorati G, Pagliacci MC, Grignani F and Riccardi C (1991) A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods 139: 271–279
Oberhammer F, Fritsch G, Schmied M, Pavelka M, Printz D, Purchio T, Lassmann H and Schulte-Hermann R (1993) Condensation of the chromatin at the membrane of an apoptotic nucleus is not associated with activation of an endonuclease. J. Cell Sci. 104: 317–326
Kong JY and Rabkin SW (2000) Palmitate-induced apoptosis in cardiomyocytes is mediated through alterations in mitochondria: prevention by cyclosporin A. Biochim. Biophys. Acta 1485: 45–55
Breidbach T, Ngazoa E and Steverding D (2002) Trypanosoma brucei: in vitro slender-to-stumpy differentiation of culture-adapted, monomorphic bloodstream forms. Exp. Parasitol. 101: 223–230
Fukushima M (1990) Prostaglandin J2 – anti-tumour and anti-viral activities and the mechanisms involved. Eicosanoids 3: 189–199
Haberl C, Hultner L, Flugel A, Falk M, Geuenich S, Wilmanns W and Denzlinger C (1998) Release of prostaglandin D2 by murine mast cells: importance of metabolite formation for antiproliferative activity. Mediators Inflamm. 7: 79–84
Padilla J, Kaur K, Cao HJ, Smith TJ and Phipps RP (2000) Peroxisome proliferator activator receptor-gamma agonists and 15-deoxy-Delta(12,14)(12,14)-PGJ(2) induce apoptosis in normal and malignant B-lineage cells. J. Immunol. 165: 6941–6948
Raz A (1972a) Interaction of prostaglandins with blood plasma proteins. Comparative binding of prostaglandins A2, F2 and E2 to human plasma proteins. Biochem. J. 130: 631–636
Raz A (1972b) Interaction of prostaglandins with blood plasma proteins. I. Binding of prostaglandin E2 to human plasma proteins and its effect on the physiological activity of prostaglandin E2 in vitro and in vivo. Biochim. Biophys. Acta 280: 602–613
Fitzpatrick FA and Waynalda MA (1981) Albumin–lipid interactions: prostaglandin stability as a probe for characterizing binding sites on vertebrate albumins. Biochemistry 20: 6129–6134
Fitzpatrick FA, Liggett WF and Wynalda MA (1984) Albumin–eicosanoid interactions. A model system to determine their attributes and inhibition. J. Biol. Chem. 259: 2722–2727
Fitzpatrick FA and Wynalda MA (1983) Albumin-catalyzed metabolism of prostaglandin D2. Identification of products formed in vitro. J. Biol. Chem. 258: 11713–11718
Ohno K, Fukushima M, Fujiwara M and Narumiya S (1988) Induction of 68,000-dalton heat shock proteins by cyclopentenone prostaglandins. Its association with prostaglandin-induced G1 block in cell cycle progression. J. Biol. Chem. 263: 19764–19770
Hughes-Fulford M, Wu J, Kato T and Fukushima M (1985) Inhibition of DNA synthesis and cell cycle by prostaglandins independent of cyclic AMP. Adv. Prostaglandin Thromboxane Leukot. Res. 15: 401–404
Bhuyan BK, Adams EG, Badiner GJ, Li LH and Barden K (1986) Cell cycle effects of prostaglandins A1, A2, and D2 in human and murine melanoma cells in culture. Cancer Res. 46: 1688–1693
Sperandio S, de Belle I and Bredesen DE (2000) An alternative, nonapoptotic form of programmed cell death. Proc. Natl. Acad. Sci. USA 97: 14376–14381
Bursch W, Ellinger A, Gerner C, Frohwein U and Schulte-Hermann R (2000) Programmed cell death (PCD). Apoptosis, autophagic PCD, or others? Ann. NY Acad. Sci. 926: 1–12
Szallies A, Kubata BK and Duszenko M (2002) A metacaspase of Trypanosoma brucei causes loss of respiration competence and clonal death in the yeast Saccharomyces cerevisiae. FEBS Lett. 517: 144–150
Mottram JC, Helms MJ, Coombs GH and Sajid M (2003) Clan CD cysteine peptidases of parasitic protozoa. Trends Parasitol. 19: 182–187
Wang TH and Wang H (1999) Apoptosis: (2) characteristics of apoptosis. J. Formos Med. Assoc. 98: 531–542
Lorenzo HK, Susin SA, Penninger J and Kroemer G (1999) Apoptosis inducing factor (AIF): a phylogenetically old, caspase-independent effector of cell death. Cell Death Differ. 6: 516–524
Turner CM, Aslam N and Dye C (1995) Replication, differentiation, growth and the virulence of Trypanosoma brucei infections. Parasitology 111: 289–300
Hamm B, Schindler A, Mecke D and Duszenko M (1990) Differentiation of Trypanosoma brucei bloodstream trypomastigotes from long slender to short stumpy-like forms in axenic culture. Mol. Biochem. Parasitol. 40: 13–22
Vassella E, Reuner B, Yutzy B and Boshart M (1997) Differentiation of African trypanosomes is controlled by a density sensing mechanism which signals cell cycle arrest via the cAMP pathway. J. Cell Sci. 110: 2661–2671
Bodley AL, McGarry MW and Shapiro TA (1995) Drug cytotoxicity assay for African trypanosomes and Leishmania species. J. Infect. Dis. 172: 1157–1159
Hirsch JG and Fedorko ME (1968) Ultrastructure of human leukocytes after simultaneous fixation with glutaraldehyde and osmium tetroxide and ‘postfixation’ in uranyl acetate. J. Cell Biol. 38: 615–627
Glauert AM, Butterworth AE, Sturrock RF and Houba V (1978) The mechansim of antibody-dependent, eosinophil-mediated damage to schistosomula of Schistosoma mansoni in vitro: a study by phase-contrast and electron microscopy. J. Cell Sci. 34: 173–192
Madeo F, Frohlich E and Frohlich KU (1997) A yeast mutant showing diagnostic markers of early and late apoptosis. J. Cell Biol. 139: 729–734
Acknowledgements
We are most grateful for the valuable technical help from Caroline Schönfeld, Martin Schmidt and Horst Schoppmann. Moreover, we are indebted to Wyeth Pharma GmbH (Münster, Germany) for the generous gift of Nipent. This work was funded by the Deutsche Forschungsgemeinschaft (DFG); KF and NU are recipients of personal grants from DAAD (Germany) and CDCH (Venezuela), respectively.
Author information
Authors and Affiliations
Corresponding author
Additional information
Edited by RA Lockshin
Both these authors have contributed equally to this work
Rights and permissions
About this article
Cite this article
Figarella, K., Rawer, M., Uzcategui, N. et al. Prostaglandin D2 induces programmed cell death in Trypanosoma brucei bloodstream form. Cell Death Differ 12, 335–346 (2005). https://doi.org/10.1038/sj.cdd.4401564
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.cdd.4401564
Keywords
This article is cited by
-
Staurosporine: new lease of life for parent compound of today’s novel and highly successful anti-cancer drugs
The Journal of Antibiotics (2018)
-
A functional BH3 domain in an aquaporin from Leishmania infantum
Cell Death Discovery (2016)
-
Cell death in parasitic protozoa: regulated or incidental?
Nature Reviews Microbiology (2013)
-
Apoptosis-like cell death pathways in the unicellular parasite Toxoplasma gondii following treatment with apoptosis inducers and chemotherapeutic agents: a proof-of-concept study
Apoptosis (2013)
-
Spliced leader RNA silencing (SLS) - a programmed cell death pathway in Trypanosoma brucei that is induced upon ER stress
Parasites & Vectors (2012)